- Conditions
- Diabetes Mellitus, Ischemic Heart Disease
- Interventions
- 100 million Allogeneic Mesenchymal Human Stem Cells, Placebo
- Drug · Other
- Lead sponsor
- Joshua M Hare
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 26 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 1
- States / cities
- Miami, Florida
Source: ClinicalTrials.gov public record
Updated Sep 1, 2025 · Synced May 21, 2026, 7:10 PM EDT